Dataset Information


Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.

ABSTRACT: Evidence suggests that MDM2 T309G polymorphism may be a risk factor for several cancers. Increasing investigations have been conducted on the association of MDM2 T309G polymorphisms with lung cancer risk and have yielded conflicting results. Previous meta-analyses on this issue have reported inconclusive data. The aim of the present study was to derive a more precise estimation of the relationship.Updated meta-analyses examining the association between MDM2 T309G polymorphism and lung cancer risk were performed. Separate analyses on ethnicity, smoking status, histological types and gender as well as source of controls were also implemented. Eligible studies were identified for the period up to Feb 2012. Lastly, ten publications including eleven case-control studies were selected for analysis. The overall data failed to indicate a significant association between MDM2 T309G polymorphism and lung cancer risk (GG vs TT OR = 1.14; 95%CI = 0.95-1.37; dominant model: OR = 1.05; 95%CI = 0.92-1.19; recessive model: OR = 1.12; 95%CI = 0.99-1.27). In a subgroup analysis by smoking status, increased lung cancer risk was shown among never-smokers (GG vs TT: OR = 1.76; 95%CI = 1.36-2.29; dominant model: OR = 1.48; 95%CI = 1.22-1.81; recessive model: OR = 1.37; 95%CI = 1.11-1.69). In subgroup analysis by gender, elevated risk was presented among women under a recessive model (OR = 1.29; 95%CI = 1.04-1.59). In the subgroup analysis by ethnicity, histological types and source of controls, no marked associations were observed.Compared to the previous meta-analyses, the results of this study confirmed that MDM2 T309G polymorphism might be a risk factor for lung cancer among never-smokers. However, the data failed to suggest a marked association between the G allele of MDM2 T309G and lung cancer risk among Asians. More interestingly, subgroup analysis by gender indicated that homozygous GG alleles might raise lung cancer risk among females.


PROVIDER: S-EPMC3402389 | BioStudies | 2012-01-01


REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4483806 | BioStudies
2016-01-01 | S-EPMC4782892 | BioStudies
2016-01-01 | S-EPMC4998362 | BioStudies
2017-01-01 | S-EPMC5700397 | BioStudies
2015-01-01 | S-EPMC4612961 | BioStudies
2020-01-01 | S-EPMC7049506 | BioStudies
2013-01-01 | S-EPMC3561416 | BioStudies
2013-01-01 | S-EPMC4029393 | BioStudies
2013-01-01 | S-EPMC3857251 | BioStudies
2020-01-01 | S-EPMC7214377 | BioStudies